# Remifentanil for General Anesthesia in Preeclamptics

> **NCT00567957** · PHASE4 · UNKNOWN · sponsor: **Istanbul University** · enrollment: 50 (estimated)

## Conditions studied

- Pre-Eclampsia
- Hypertension, Pregnancy-Induced
- Pregnancy Complications

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00567957
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567957, "Remifentanil for General Anesthesia in Preeclamptics". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00567957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*